@article{fdi:010088717,
  title = {{T}uberculosis incidence in foreign-born people residing in {E}uropean countries in 2020},
  author = {{V}asiliu, {A}. and {K}{\¨o}hler, {N}. and {A}ltpeter, {E}. and Ægisdottir, {T}. {R}. and {A}merali, {M}. and de {O}ñate, {W}. {A}. and {B}akos, {A}. and {D}'{A}mato, {S}. and {C}irillo, {D}. {M}. and van {C}revel, {R}. and {D}avidaviciene, {E}. and {D}emuth, {I}. and {D}omínguez, {J}. and {D}uarte, {R}. and {G}ünther, {G}. and {G}uthmann, {J}. {P}. and {H}atzianastasiou, {S}. and {H}olm, {L}. {H}. and {H}errador, {Z}. and {H}ribar, {U}. and {H}uberty, {C}. and {I}braim, {E}. and {J}ackson, {S}. and {J}ensenius, {M}. and {J}osefsdottir, {K}. {S}. and {K}och, {A}. and {K}orzeniewska-{K}osela, {M}. and {K}uksa, {L}. and {K}unstt, {H}. and {L}ienhardt, {C}hristian and {M}ahler, {B}. and {M}akek, {M}. {J}. and {M}uylle, {I}. and {N}ormark, {J}. and {P}ace-{A}sciak, {A}. and {P}etrovic, {G}. and {P}ieridou, {D}. and {R}usso, {G}. and {R}zhepishevska, {O}. and {S}alzer, {H}. {J}. {F}. and {M}arques, {M}. {S}. and {S}chmid, {D}. and {S}olovic, {I}. and {S}ukholytka, {M}. and {S}vetina, {P}. and {T}yufekchieva, {M}. and {V}asankari, {T}. and {V}iiklepp, {P}. and {V}illand, {K}. and {W}allenfels, {J}. and {W}esolowski, {S}. and {M}andalakas, {A}. {M}. and {Z}enner, {D}. and {L}ange, {C}. and {T}bnet, and {M}artinez, {L}.},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground: {E}uropean-specific policies for tuberculosis ({TB}) elimination require identification of key populations that benefit from {TB} screening. {A}im: {W}e aimed to identify groups of foreign-born individuals residing in {E}uropean countries that benefit most from targeted {TB} prevention screening. {M}ethods: {T}he {T}uberculosis {N}etwork {E}uropean {T}rials group collected, by cross-sectional survey, numbers of foreign-born {TB} patients residing in {E}uropean {U}nion ({EU}) countries, {I}celand, {N}orway, {S}witzerland and the {U}nited {K}ingdom ({UK}) in 2020 from the 10 highest ranked countries of origin in terms of {TB} cases in each country of residence. {T}uberculosis incidence rates ({IR}s) in countries of residence were compared with countries of origin. {R}esults: {D}ata on 9,116 foreign-born {TB} patients in 30 countries of residence were collected. {M}ain countries of origin were {E}ritrea, {I}ndia, {P}akistan, {M}orocco, {R}omania and {S}omalia. {T}uberculosis {IR}s were highest in patients of {E}ritrean and {S}omali origin in {G}reece and {M}alta (both > 1,000/100,000) and lowest among {U}krainian patients in {P}oland (3.6/100,000). {T}hey were mainly lower in countries of residence than countries of origin. {H}owever, {IR}s among {E}ritreans and {S}omalis in {G}reece and {M}alta were five times higher than in {E}ritrea and {S}omalia. {S}imilarly, {IR}s among {E}ritreans in {G}ermany, the {N}etherlands and the {UK} were four times higher than in {E}ritrea. {C}onclusions: {C}ountry of origin {TB} {IR} is an insufficient indicator when targeting foreign-born populations for active case finding or {TB} prevention policies in the countries covered here. {E}limination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks.},
  keywords = {{EUROPE}},
  booktitle = {},
  journal = {{E}urosurveillance},
  volume = {28},
  numero = {42},
  pages = {2300051 [11 p.]},
  ISSN = {1025-496{X}},
  year = {2023},
  DOI = {10.2807/1560-7917.{E}s.2023.28.42.2300051},
  URL = {https://www.documentation.ird.fr/hor/fdi:010088717},
}